Your Messages Inbox
Your Article Summary
See Latest ArticlesAlcon and AstraZeneca to Collaborate on Eye Drug Development
Alcon, 07/23/09
Alcon announced that it has entered into a five–year collaborative research agreement with AstraZeneca for the exclusive ophthalmic discovery and potential development rights to AstraZeneca's compound library. The agreement matches Alcon's specific ophthalmic research capability with AstraZeneca's rich drug libraries and covers multiple classes of small molecules with lead compounds that already have been identified to have a strong scientific rationale for utility in ophthalmic disease.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Omnicell Gets Cabinet Deal in Carolinas
HealthDataManagement, 12/16/09
Array BioPharma and Amgen Partner in Type 2 Diabetes
Amgen, 12/15/09
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
deCODE Discovers A Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin
deCODE genetics, 12/17/09
The Medtronic Foundation Offers Grants to Schools Participating in Online Sudden Cardiac Arrest Response Training
Medtronic, 12/17/09
AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease
AstraZeneca, 12/16/09
Article Search
Sponsor